CN116421784A - Osteochondral tissue repair scaffold and preparation method thereof - Google Patents
Osteochondral tissue repair scaffold and preparation method thereof Download PDFInfo
- Publication number
- CN116421784A CN116421784A CN202210012234.2A CN202210012234A CN116421784A CN 116421784 A CN116421784 A CN 116421784A CN 202210012234 A CN202210012234 A CN 202210012234A CN 116421784 A CN116421784 A CN 116421784A
- Authority
- CN
- China
- Prior art keywords
- layer
- cartilage
- tissue repair
- scaffold
- osteochondral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
- B33Y70/10—Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P10/00—Technologies related to metal processing
- Y02P10/25—Process efficiency
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Ceramic Engineering (AREA)
- Civil Engineering (AREA)
- Composite Materials (AREA)
- Structural Engineering (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域technical field
本发明属于生物医用材料技术领域,具体涉及一种促细胞迁移的一体化骨软骨组织修复支架及其制备方法。The invention belongs to the technical field of biomedical materials, and in particular relates to an integrated osteochondral tissue repair scaffold for promoting cell migration and a preparation method thereof.
背景技术Background technique
膝关节的软骨损伤主要由外伤、疾病或衰老造成,这会影响患者的正常生活并引起疼痛。关节软骨是由软骨细胞和细胞外基质(ECM)(例如Ⅱ型胶原蛋白和蛋白聚糖)组成,是一种没有血管、淋巴或神经的光滑的弹性组织,在受损时具有有限的自愈能力。根据软骨损伤深度,通常可以分为三种类型:部分软骨缺损、全层软骨缺损以及骨软骨缺损,然而,临床研究表明,软骨损伤总是深深地延伸到软骨下骨中,导致膝关节的骨软骨缺损。如果不及时加以治疗,骨软骨缺损可能会进一步加重关节软骨缺损并导致骨关节炎。并且基于骨软骨天然的复杂结构,软骨和软骨下骨是具有明显生物学特异性的两种组织,这意味着骨软骨损伤的临床治疗更具挑战性。因此,骨软骨缺损修复至关重要。但是,目前的传统治疗和手术方法只能暂时缓解患者的疼痛,不能真正实现骨软骨缺损修复和具有完整功能的透明软骨再生。因此,面对骨软骨修复的临床难题,提出新的治疗方法十分迫切。Cartilage damage in the knee joint is mainly caused by trauma, disease or aging, which affects the normal life of patients and causes pain. Composed of chondrocytes and extracellular matrix (ECM) such as type II collagen and proteoglycans, articular cartilage is a smooth, elastic tissue without blood vessels, lymphatics, or nerves that has limited self-healing when damaged ability. According to the depth of cartilage damage, it can usually be divided into three types: partial cartilage defect, full-thickness cartilage defect and osteochondral defect. However, clinical studies have shown that cartilage damage always extends deeply into the subchondral bone, resulting in knee joint damage Osteochondral defect. If left untreated, osteochondral defects can further aggravate articular cartilage defects and lead to osteoarthritis. And based on the natural complex structure of osteochondral bone, cartilage and subchondral bone are two tissues with obvious biological specificity, which means that the clinical treatment of osteochondral injury is more challenging. Therefore, the repair of osteochondral defects is very important. However, the current traditional treatment and surgical methods can only temporarily relieve the pain of patients, and cannot truly repair osteochondral defects and regenerate hyaline cartilage with complete functions. Therefore, facing the clinical problems of osteochondral repair, it is urgent to propose new treatment methods.
组织工程是一个新兴领域,已经给体内移植以及组织和器官的再生带来了新的希望。近些年来,组织工程已逐渐成为一项有效而又前沿的治疗关节软骨损伤的方法。但目前组织工程中的骨软骨支架仍存在一些待解决的问题,例如非分层支架修复收效甚微、多层支架层间缺乏有效的界面结合性。而3D打印技术在组织工程支架材料的制备中有较多研究,并显现出优势。利用3D打印技术打印的支架材料具有与缺损组织相匹配的外形,还有可以提供细胞粘附、生长和增殖的内部三维多孔结构,通过材料筛选及改性可以制备3D打印“生物墨水”,利用3D生物打印机可以打印制备机械性能良好的支架材料。DLP作为光打印中新技术,目前已经展现出诸多优点。比如,打印速度快、打印精度高、有利于细胞存活等,已经在组织工程领域多个研究方向进行使用。Tissue engineering is an emerging field that has brought new hope for in vivo transplantation and regeneration of tissues and organs. In recent years, tissue engineering has gradually become an effective and cutting-edge method for the treatment of articular cartilage injuries. However, there are still some problems to be solved in the osteochondral scaffolds in tissue engineering, such as the non-layered scaffolds have little repair effect and the lack of effective interfacial bonding between the layers of the multilayer scaffolds. However, 3D printing technology has been studied more in the preparation of tissue engineering scaffold materials, and has shown advantages. The scaffold material printed by 3D printing technology has a shape that matches the defect tissue, as well as an internal three-dimensional porous structure that can provide cell adhesion, growth and proliferation. Through material screening and modification, 3D printing "bio-ink" can be prepared. 3D bioprinters can print scaffolds with good mechanical properties. As a new technology in optical printing, DLP has already demonstrated many advantages. For example, the printing speed is fast, the printing precision is high, and it is conducive to cell survival, etc., which have been used in many research directions in the field of tissue engineering.
之前有研究证明,多孔状结构的支架有利于促进细胞迁移,并且不同的结构也会影响支架力学性能,因此为了促进组织再生,构建影响细胞和组织命运的理想支架微环境是必不可少的。CN101810885B提供了一种带有圆形孔和垂直孔的双层仿生骨软骨组织工程支架,但其支架中的圆形孔和垂直孔的形成是来自于材料本身的特性,本发明中使用的GelMA水凝胶也具有相似的多孔结构,并且孔的分布是随机的,孔径大小难以实现精准控制,严重影响软骨细胞的迁移和生长,仿生程度较低,软骨修复效果不佳。Previous studies have proved that scaffolds with porous structures are conducive to promoting cell migration, and different structures can also affect the mechanical properties of scaffolds. Therefore, in order to promote tissue regeneration, it is essential to construct an ideal scaffold microenvironment that affects the fate of cells and tissues. CN101810885B provides a double-layer bionic osteochondral tissue engineering support with circular holes and vertical holes, but the formation of the circular holes and vertical holes in the support comes from the characteristics of the material itself, GelMA used in the present invention Hydrogel also has a similar porous structure, and the distribution of pores is random. It is difficult to precisely control the pore size, which seriously affects the migration and growth of chondrocytes. The degree of biomimesis is low, and the effect of cartilage repair is not good.
因此,通过DLP打印技术可以一体化构建多层骨软骨支架结构,实现个性化定制,有效仿生天然骨软骨特异的物理和生物学特性。Therefore, DLP printing technology can be used to construct a multi-layer osteochondral scaffold structure in an integrated manner, realize personalized customization, and effectively mimic the specific physical and biological characteristics of natural osteochondral.
发明内容Contents of the invention
为解决上述问题,本发明提供了一种新型骨软骨组织修复支架,所述骨软骨组织修复支架为水凝胶支架,并由自制的光固化3D打印设备一体化制作而成,包括仿生的双层结构:软骨层和软骨下骨层,所述软骨层具有“莲藕状”和“辐射状”的孔隙,所述软骨下骨层具有“莲藕状”的孔隙,且所述软骨层和软骨下骨层之间的纵向孔隙相互贯通,精确控制孔径,并且还可以在软骨下骨层中添加粒径为1纳米的磷酸钙纳米簇材料。本发明的目的在于提供一种生物相容性好、力学性能佳、仿生程度高、更利于软骨细胞和骨髓间充质干细胞迁移和促进骨软骨缺损修复的水凝胶骨软骨组织修复支架及其制备方法。In order to solve the above problems, the present invention provides a novel scaffold for osteochondral tissue repair. The scaffold for osteochondral tissue repair is a hydrogel scaffold, which is integrally produced by self-made light-curing 3D printing equipment, including bionic double Layer structure: cartilage layer and subchondral bone layer, the cartilage layer has "lotus root-like" and "radial" pores, the subchondral bone layer has "lotus root-like" pores, and the cartilage layer and The longitudinal pores between the bone layers are connected to each other, and the pore size can be precisely controlled, and calcium phosphate nano-cluster materials with a particle size of 1 nanometer can also be added to the subchondral bone layer. The purpose of the present invention is to provide a hydrogel osteochondral tissue repair scaffold with good biocompatibility, good mechanical properties, high bionic degree, which is more conducive to the migration of chondrocytes and bone marrow mesenchymal stem cells and promotes the repair of osteochondral defects and its Preparation.
虽然用于制备修复支架的水凝胶本身材质中也可能带有随机分布的垂直孔和圆形孔,但其软骨修复效果依然较差。本发明提供的骨软骨组织修复支架,由自制的光固化3D打印设备一体化制作而成,能精准控制骨软骨组织修复支架的水凝胶微孔的排布和孔径,从而实现更好的骨软骨缺损修复效果。Although the hydrogel used to prepare the repair scaffold may have randomly distributed vertical and circular holes in its material, its cartilage repair effect is still poor. The osteochondral tissue repair scaffold provided by the present invention is integrally produced by self-made light-curing 3D printing equipment, which can precisely control the arrangement and pore size of the hydrogel micropores of the osteochondral tissue repair scaffold, thereby achieving better osteochondral tissue repair. Cartilage defect repair effect.
一方面本发明提供了一种骨软骨组织修复支架,从上到下依次包括软骨层和软骨下骨层,所述软骨层具备“莲藕状”和“辐射状”分布的孔;所述软骨下骨层具备和软骨层贯通的“莲藕状”孔。On the one hand, the present invention provides a scaffold for repairing osteochondral tissue, which includes a cartilage layer and a subchondral bone layer from top to bottom, and the cartilage layer has holes distributed in "lotus root shape" and "radial shape"; the subchondral bone layer The bone layer has "lotus root-shaped" holes that communicate with the cartilage layer.
本发明所述“莲藕状”和“辐射状”孔都为条状的贯穿孔。Both the "lotus root-shaped" and "radial" holes in the present invention are strip-shaped through holes.
本发明经过大量研究证实,骨软骨修复支架中的孔的形状和孔径大小对支架的力学特性和细胞迁移具有显著影响,必须精准控制孔的形状、分布及孔径大小,才能获得合适的力学特性,以及具有更好的细胞迁移效果,从而才能具有更好的软骨修复效果。The present invention has been proved by a large number of studies that the shape and diameter of the pores in the osteochondral repair scaffold have a significant impact on the mechanical properties and cell migration of the scaffold, and the shape, distribution and diameter of the pores must be precisely controlled to obtain suitable mechanical properties. And have a better cell migration effect, so as to have a better cartilage repair effect.
本发明所述的“莲藕状”孔是指垂直于支架的纵向贯通排列孔(详见图1和图2);“辐射状”孔是指以横向贯穿支架的横向孔,并以横截面圆心为中心,向外辐射的孔,呈横向排列(详见图1和图2)。The "lotus root-shaped" hole in the present invention refers to the longitudinal through arrangement of holes perpendicular to the bracket (see Figure 1 and Figure 2 for details); As the center, the holes radiating outward are arranged in a horizontal direction (see Figure 1 and Figure 2 for details).
所述软骨层具备“莲藕状”和“辐射状”分布的孔,以有利于软骨细胞迁移和分布;所述软骨下骨层具有“莲藕状”的孔,以引导骨髓间充质干细胞(BMSCs)迁移到上部空间。The cartilage layer has "lotus root-shaped" and "radial" pores to facilitate the migration and distribution of chondrocytes; the subchondral bone layer has "lotus root-shaped" pores to guide bone marrow mesenchymal stem cells (BMSCs) ) to the upper space.
进一步地,所述软骨层和软骨下骨层都为圆柱形,且软骨层和软骨下骨层的圆柱形底面直径一致。Further, both the cartilage layer and the subchondral bone layer are cylindrical, and the diameters of the cylindrical bottom surfaces of the cartilage layer and the subchondral bone layer are consistent.
进一步地,所述“莲藕状”孔纵向贯穿了软骨层和软骨下骨层的圆柱形底面,软骨下骨层和软骨层的“莲藕状”孔连通成一体。Further, the "lotus root-shaped" holes longitudinally penetrate the cylindrical bottom surfaces of the cartilage layer and the subchondral bone layer, and the "lotus root-shaped" holes of the subchondral bone layer and the cartilage layer are connected into one body.
进一步地,所述“辐射状”孔横向贯穿了软骨层,且经过了软骨层的横截面圆心。Further, the "radial" holes transversely penetrate the cartilage layer and pass through the center of the cross-section of the cartilage layer.
进一步地,所述软骨层和软骨下层的孔隙直径为100~400μm。Further, the pore diameter of the cartilage layer and the subchondral layer is 100-400 μm.
支架中相互连接的孔隙结构可形成强大的三维组织,有利于细胞增殖分化和营养物质/废物转移,从而实现高效的组织再生。并且孔隙大小可调节细胞命运,足够大的孔隙为骨形成提供足够的成骨生态位,而足够小的孔隙将维持干细胞性并防止分化。The interconnected pore structure in the scaffold can form a strong three-dimensional organization, which is conducive to cell proliferation and differentiation and nutrient/waste transfer, thereby achieving efficient tissue regeneration. And pore size can regulate cell fate, large enough pores provide a sufficient osteogenic niche for bone formation, while small enough pores will maintain stemness and prevent differentiation.
软骨下骨层支架垂直的孔洞,有利于骨髓间充质干细胞向上层进行迁移,并且“莲藕状”的支架力学性能强于上层,有利于骨的修复。The vertical holes in the subchondral bone layer scaffold are conducive to the migration of bone marrow mesenchymal stem cells to the upper layer, and the "lotus root-shaped" scaffold has stronger mechanical properties than the upper layer, which is conducive to bone repair.
软骨层水凝胶支架具备“莲藕状”和“辐射状”分布的孔,不仅有利于骨髓间充质干细胞的迁移,也有利于周围正常的软骨细胞向受损区域迁移,加强软骨层的修复。The cartilage layer hydrogel scaffold has "lotus root-shaped" and "radial" distribution of holes, which not only facilitates the migration of bone marrow mesenchymal stem cells, but also facilitates the migration of surrounding normal chondrocytes to the damaged area, strengthening the repair of the cartilage layer .
包含软骨层和软骨下骨层的支架是有利于细胞迁入、营养物质运输和血管长入的多孔支架,其机械强度和生物学性能都适用于骨软骨的再生和修复。The scaffold including the cartilage layer and the subchondral bone layer is a porous scaffold that facilitates the migration of cells, the transportation of nutrients and the ingrowth of blood vessels, and its mechanical strength and biological properties are suitable for the regeneration and repair of osteochondral.
进一步地,所述“辐射状”孔可设有一层或一层以上,每层之间的间隔大于100μm,均匀分布于软骨层。Furthermore, the "radial" holes can be provided in one or more layers, with the interval between each layer being greater than 100 μm, and evenly distributed in the cartilage layer.
进一步地,所述每层设有2~10条横向贯穿软骨层且经过横截面圆心的“辐射状”孔。Further, each layer is provided with 2 to 10 "radial" holes that traverse the cartilage layer and pass through the center of the cross-section.
进一步地,在同一层的相邻两条“辐射状”孔之间夹角都保持一致。Furthermore, the included angles between two adjacent "radial" holes on the same layer are kept consistent.
进一步地,所述“莲藕状”孔可设置多条,每条之间的间距大于100μm,纵向均匀分布于软骨层和软骨下骨层的横截面。Further, the "lotus root-shaped" holes can be arranged in multiples, and the distance between each hole is greater than 100 μm, and they are evenly distributed in the cross-section of the cartilage layer and the subchondral bone layer in the longitudinal direction.
进一步地,所述骨软骨组织修复支架的尺寸大小根据实际需移植的人体或动物骨软骨尺寸进行匹配设计。Further, the size of the osteochondral tissue repair scaffold is designed to match the size of the actual human or animal osteochondral to be transplanted.
在一些方式中,本发明提供的软骨修复支架的尺寸为所述多层骨软骨组织修复支架的厚度为4mm,所述软骨层的厚度为1mm,所述软骨下骨层的厚度为3mm,孔径为200μm的微孔。该尺寸规格的软骨修复支架主要用于匹配动物实验兔子骨软骨造模。In some ways, the size of the cartilage repair scaffold provided by the present invention is that the thickness of the multilayer osteochondral tissue repair scaffold is 4 mm, the thickness of the cartilage layer is 1 mm, the thickness of the subchondral bone layer is 3 mm, and the aperture is Micropores of 200 μm. The cartilage repair scaffold of this size is mainly used to match the animal experiment rabbit osteochondral modeling.
进一步地,所述软骨层包括GelMA、LAP和生长因子。Further, the cartilage layer includes GelMA, LAP and growth factors.
进一步地,所述软骨下骨层包括GelMA和LAP。Further, the subchondral bone layer includes GelMA and LAP.
进一步地,所述软骨下骨层还包括粒径为1纳米的磷酸钙纳米簇材料。Further, the subchondral bone layer also includes calcium phosphate nano-cluster materials with a particle size of 1 nanometer.
本发明所述粒径为1纳米的磷酸钙纳米簇材料是根据CN109718249A中的磷酸钙纳米簇制得。The calcium phosphate nano-cluster material with a particle size of 1 nanometer in the present invention is prepared according to the calcium phosphate nano-cluster in CN109718249A.
羟基磷灰石是人体和动物骨骼的主要无机成分,普通羟基磷灰石主要用于制备功能化复合材料。现有的纳米羟基磷灰石,其粒径普遍在10纳米以上,多用于骨组织工程支架材料。Hydroxyapatite is the main inorganic component of human and animal bones, and ordinary hydroxyapatite is mainly used to prepare functional composite materials. The existing nano-hydroxyapatite has a particle size of more than 10 nanometers and is mostly used as a scaffold material for bone tissue engineering.
本发明采用的粒径为1纳米的磷酸钙纳米簇材料由研究团队自主研发,其制备方法已申请专利CN109718249A,主要用于制备修复骨质疏松的药物,并能有效促进牙釉质的再生。The calcium phosphate nanocluster material with a particle size of 1 nanometer used in the present invention is independently developed by the research team, and its preparation method has applied for patent CN109718249A. It is mainly used to prepare drugs for repairing osteoporosis, and can effectively promote the regeneration of tooth enamel.
本发明经大量研究发现,采用所述的粒径为1纳米的磷酸钙纳米簇材料用于制备软骨组织修复支架时,因其粒径更小,不仅具有更好的生物相容性,还具备更好的仿生效果,能有效促进间充质干细胞的成骨分化,软骨组织修复效果更好。After a lot of research, the present invention finds that when the calcium phosphate nanocluster material with a particle size of 1 nanometer is used to prepare a scaffold for cartilage tissue repair, it not only has better biocompatibility because of its smaller particle size, but also has Better bionic effect can effectively promote the osteogenic differentiation of mesenchymal stem cells, and the cartilage tissue repair effect is better.
进一步地,所述软骨层和软骨下骨层的GelMA和LAP浓度相同。Further, the GelMA and LAP concentrations of the cartilage layer and the subchondral bone layer are the same.
进一步地,所述GelMA含量为15%,所述LAP含量为0.2%。Further, the GelMA content is 15%, and the LAP content is 0.2%.
进一步地,所述生长因子为KGN,所述KGN的浓度为200μM。Further, the growth factor is KGN, and the concentration of KGN is 200 μM.
另一方面,本发明提供了一种骨软骨组织修复支架的制备方法,其特征在于,所述制备方法包括:On the other hand, the present invention provides a preparation method of osteochondral tissue repair scaffold, it is characterized in that, described preparation method comprises:
(1)配制第一料液,将GelMA、LAP及KGN,在避光的条件下加入到单蒸水中,搅拌均匀后,得到第一料液。所述第一料液包括GelMA、LAP和生长因子,用于制备软骨层;(1) To prepare the first feed liquid, add GelMA, LAP and KGN into single distilled water under the condition of avoiding light, and stir evenly to obtain the first feed liquid. The first feed solution includes GelMA, LAP and growth factors for preparing the cartilage layer;
(2)配制第二料液,将GelMA、LAP,或GelMA、LAP、粒径为1纳米的磷酸钙纳米簇材料,在避光的条件下加入到单蒸水中,搅拌均匀后,得到第二料液。所述第二料液中包括GelMA、LAP和1纳米羟基磷灰石,用于制备软骨下骨层;(2) Prepare the second feed liquid, GelMA, LAP, or GelMA, LAP, calcium phosphate nano-cluster material with a particle size of 1 nanometer are added to single distilled water under the condition of avoiding light, and after stirring evenly, the second Liquid. The second feed solution includes GelMA, LAP and 1 nanometer hydroxyapatite for preparing subchondral bone layer;
(3)将所述第一料液倒入光固化3D打印设备液体槽,进行打印,待上层软骨层支架全部打印完毕,得到上层软骨层水凝胶支架;(3) Pour the first material liquid into the liquid tank of the light-curing 3D printing device for printing, and after the upper cartilage layer support is completely printed, the upper cartilage layer hydrogel support is obtained;
(4)清理打印机液体槽后,将所述第二料液倒入打印机液体槽,继续进行打印,待下层软骨下骨层支架全部打印完毕,得到双层骨软骨组织修复支架。(4) After cleaning the liquid tank of the printer, pour the second material liquid into the liquid tank of the printer, and continue printing. After all the lower subchondral bone layer brackets are printed, a double-layer bone cartilage tissue repair bracket is obtained.
依据仿生学的原理以及正常骨软骨缺损的大小及结构,应用计算机辅助设计软件建立具有特定外形和仿生空间结构的双层骨软骨组织一体化修复支架CAD模型;将设计好的双层骨软骨组织修复支架CAD模型通过软件转化成适用于自主设计研发的基于紫外光照投影的光固化3D打印设备的Task Scheduler Task Object(.job)文件格式,并导入到所述的3D打印设备中,使用紫外光固化打印系统,按照预先设定的参数,对所述第一料液和所述第二料液通过自制光固化3D打印设备进行打印,即可得到具备精准孔排列和孔径的骨软骨组织修复支架结构。该支架结构从上到下分为软骨层和软骨下骨层,所述软骨层具备“莲藕状”和“辐射状”分布的孔,即其中的孔隙结构横向和纵向排列,以有利于软骨细胞迁移和分布;而所述软骨下骨层则具有“莲藕状”的孔,即孔隙结构纵向排列,以引导骨髓间充质干细胞(BMSCs)迁移到上部空间;且所述软骨层和软骨下骨层之间的纵向“莲藕状”孔隙相互贯通。Based on the principles of bionics and the size and structure of normal osteochondral defects, a CAD model of a double-layer osteochondral tissue integrated repair scaffold with a specific shape and bionic space structure was established by using computer-aided design software; the designed double-layer osteochondral tissue The repair bracket CAD model is converted into the Task Scheduler Task Object (.job) file format suitable for the self-designed and developed UV light projection-based light-curing 3D printing equipment through software, and imported into the 3D printing equipment, using ultraviolet light The curing printing system prints the first material liquid and the second material liquid through self-made photo-curing 3D printing equipment according to the preset parameters, and then obtains the osteochondral tissue repair scaffold with precise hole arrangement and pore size structure. The scaffold structure is divided into a cartilage layer and a subchondral bone layer from top to bottom. The cartilage layer has pores distributed in a "lotus root shape" and a "radial shape", that is, the pore structure is arranged horizontally and vertically to facilitate chondrocytes. Migration and distribution; and the subchondral bone layer has "lotus root-shaped" pores, that is, the pore structure is arranged longitudinally to guide bone marrow mesenchymal stem cells (BMSCs) to migrate to the upper space; and the cartilage layer and subchondral bone The longitudinal "lotus root-shaped" pores between the layers are interconnected.
本发明采用的自制光固化3D打印设备,该打印设备按照已申请专利CN110228193A的方法制备,可以实现边光固化边打印,并能精准控制骨软骨组织修复支架的孔径和孔的排布方式,从而能实现更好的软骨组织修复效果。The self-made light-curing 3D printing equipment used in the present invention is prepared according to the method of the patent CN110228193A, which can realize printing while light-curing, and can precisely control the aperture and hole arrangement of the osteochondral tissue repair bracket, thereby Can achieve better cartilage tissue repair effect.
本发明涉及的双层骨软骨组织修复支架是通过模拟天然骨软骨的生理结构与组成构建,其中上、下层均可在原组分的基础上添加不同的生长因子、无机离子或有机成分,例如KGN、BMP、TGF-β1等。The double-layer osteochondral tissue repair scaffold involved in the present invention is constructed by simulating the physiological structure and composition of natural osteochondral, wherein the upper and lower layers can be added with different growth factors, inorganic ions or organic components on the basis of the original components, such as KGN , BMP, TGF-β1, etc.
虽然GelMA水凝胶本身也带有随机分布的垂直孔和圆形孔,但其细胞迁移效果仍然较差,难以实现足够的缺损修复效果;本发明通过光固化3D打印设备打印特定的200μm孔径的“莲藕状”和“辐射状”孔结构的凝胶,能明显提升促进细胞迁移的效果,从而大幅提升缺损修复的效果。Although the GelMA hydrogel itself also has randomly distributed vertical holes and circular holes, its cell migration effect is still poor, and it is difficult to achieve a sufficient defect repair effect; The gel with "lotus root shape" and "radial" pore structure can significantly improve the effect of promoting cell migration, thereby greatly improving the effect of defect repair.
本发明提供的骨软骨组织修复支架具有以下有益效果:The osteochondral tissue repair scaffold provided by the present invention has the following beneficial effects:
(1)通过自制光固化3D打印设备精确打印,制得的骨软骨组织修复支架具备精确的孔径和孔的排布方式,对细胞迁移有很好的效果;(1) Precisely printed by self-made light-curing 3D printing equipment, the prepared osteochondral tissue repair scaffold has precise pore size and pore arrangement, and has a good effect on cell migration;
(2)将粒径为1纳米的磷酸钙纳米簇材料用于骨软骨修复支架的制备,具有比普通羟基磷灰石具有更好的成骨诱导性能;(2) The calcium phosphate nanocluster material with a particle size of 1 nanometer is used in the preparation of osteochondral repair scaffolds, which has better osteoinductive properties than ordinary hydroxyapatite;
(3)具有可调节的机械性能和良好的生物相容性;(3) It has adjustable mechanical properties and good biocompatibility;
(4)具有更好的促软骨细胞和骨髓间充质干细胞迁移的能力;(4) have a better ability to promote the migration of chondrocytes and bone marrow mesenchymal stem cells;
(5)具有营养物质运输/废物转移的能力;(5) Capable of nutrient transport/waste transfer;
(6)具有可使新生血管长入和更好的促进骨软骨缺损修复能力。(6) It has the ability to grow new blood vessels and better promote the repair of osteochondral defects.
附图说明Description of drawings
图1为实施例1中的骨软骨组织修复支架的结构示意图。FIG. 1 is a schematic structural view of the osteochondral tissue repair scaffold in Example 1.
图2为实施例1中的骨软骨组织修复支架的剖面图。FIG. 2 is a cross-sectional view of the osteochondral tissue repair scaffold in Example 1. FIG.
图3为实施例1中的骨软骨组织修复支架的设计图。FIG. 3 is a design diagram of the osteochondral tissue repair scaffold in Example 1. FIG.
图4为实施例1中的骨软骨组织修复支架的3D模型及制备示意图。FIG. 4 is a 3D model and a schematic diagram of preparation of the osteochondral tissue repair scaffold in Example 1. FIG.
图5为实施例1中的骨软骨组织修复支架的大体图。FIG. 5 is a general view of the scaffold for repairing osteochondral tissue in Example 1. FIG.
图6为实施例1中的骨软骨组织修复支架中孔隙的荧光图和电镜图。FIG. 6 is a fluorescence image and an electron microscope image of pores in the scaffold for repairing osteochondral tissue in Example 1. FIG.
图7为实施例2中的骨软骨组织修复支架中不同孔径的上层软骨层支架微观结构图。Fig. 7 is a microstructure diagram of the upper cartilage layer scaffold with different pore sizes in the scaffold for repairing osteochondral tissue in Example 2.
图8为实施例2中的骨软骨组织修复支架的15%GelMA时不同孔径的力学性能。FIG. 8 shows the mechanical properties of the osteochondral tissue repair scaffold in Example 2 with 15% GelMA and different pore sizes.
图9为实施例2中的骨软骨组织修复支架的10%GelMA时不同孔径的力学性能。FIG. 9 shows the mechanical properties of the osteochondral tissue repair scaffold in Example 2 with 10% GelMA and different pore sizes.
图10为实施例2中的骨软骨组织修复支架的15%GelMA和10%GelMA的扫描电镜图。10 is a scanning electron micrograph of 15% GelMA and 10% GelMA of the bone cartilage tissue repair scaffold in Example 2.
图11为实施例3中的骨软骨组织修复支架中上下层水凝胶支架的力学性能。Fig. 11 shows the mechanical properties of the upper and lower layers of the hydrogel scaffold in the osteochondral tissue repair scaffold in Example 3.
图12为实施例4中的骨软骨组织修复支架的GelMA水凝胶的生物相容性实验结果。Fig. 12 is the biocompatibility test result of the GelMA hydrogel of the osteochondral tissue repair scaffold in Example 4.
图13为实施例5中的骨软骨组织修复支架的GelMA水凝胶的成骨诱导性能实验碱性磷酸酶染色结果。Fig. 13 is the alkaline phosphatase staining results of the osteoinductive performance experiment of the GelMA hydrogel of the osteochondral tissue repair scaffold in Example 5.
图14为实施例5中的骨软骨组织修复支架的GelMA水凝胶的成骨诱导性能实验碱性磷酸酶活性定量结果。Fig. 14 is the quantitative result of the alkaline phosphatase activity of the osteoinductive performance experiment of the GelMA hydrogel of the osteochondral tissue repair scaffold in Example 5.
图15为实施例6中骨软骨组织修复支架的体外促细胞迁移结果。Fig. 15 is the result of promoting cell migration in vitro of the osteochondral tissue repair scaffold in Example 6.
图16为实施例7中的骨软骨组织修复支架的体内细胞浸润结果。Fig. 16 is the in vivo cell infiltration result of the osteochondral tissue repair scaffold in Example 7.
图17、18、19为实施案例8中不同微孔分布的骨软骨组织修复支架的体内细胞浸润结果。Figures 17, 18, and 19 show the in vivo cell infiltration results of osteochondral tissue repair scaffolds with different micropore distributions in Example 8.
图20为实施例9中植入支架后8、16周关节样本大体图。Fig. 20 is a general view of the joint samples at 8 and 16 weeks after implantation of the stent in Example 9.
图21为实施例9中植入支架后关节样本的HE染色结果。Fig. 21 is the HE staining result of the joint sample after implanting the stent in Example 9.
图22为实施例9中植入支架后关节样本的SO染色结果。Fig. 22 is the SO staining result of the joint sample after implanting the stent in Example 9.
图23为实施例9中的植入支架后16周关节样本修复后的力学测试结果。Fig. 23 is the result of the mechanical test of the repaired
具体实施方式Detailed ways
下面结合附图和实施例对本发明作进一步详细描述,需要指出的是,以下所述实施例旨在便于对本发明的理解,而对其不起任何限定作用。根据下面说明和权利要求书,本发明的优点和特征将更清楚。需说明的是,附图均采用非常简化的形式且均使用非精准的比例,仅用以方便、明晰地辅助说明本发明实施例的目的。The present invention will be described in further detail below with reference to the accompanying drawings and embodiments. It should be noted that the following embodiments are intended to facilitate the understanding of the present invention, but do not limit it in any way. Advantages and features of the present invention will be apparent from the following description and claims. It should be noted that all the drawings are in very simplified form and use inaccurate scales, and are only used to facilitate and clearly assist the purpose of illustrating the embodiments of the present invention.
实施例1本发明提供的骨软骨组织修复支架
本实施例提供的骨软骨组织修复支架结构如图1-图3所示,其中图1为骨软骨组织修复支架的结构示意图,图2为骨软骨组织修复支架的剖面图,图3为骨软骨组织修复支架的设计图。The osteochondral tissue repair scaffold structure provided in this embodiment is shown in Figures 1-3, wherein Figure 1 is a schematic structural view of the osteochondral tissue repair scaffold, Figure 2 is a cross-sectional view of the osteochondral tissue repair scaffold, and Figure 3 is the osteochondral tissue repair scaffold Design drawing of tissue repair scaffold.
由图1、图2和图3可见,本实施例提供的骨软骨组织修复支架包括上层的软骨层1和下层的软骨下骨层2,所述软骨层1具备“莲藕状”孔3和“辐射状”孔4,所述软骨下骨层2具备与软骨层贯通的“莲藕状”的孔3;所述软骨层1和软骨下骨层2之间的“莲藕状”孔隙相互贯通。“莲藕状”孔3是指垂直于支架的纵向贯通排列孔,“辐射状”孔4是指横向贯穿支架的横向孔,并以横截面圆心为中心,向外辐射,呈横向排列。本实施例中,软骨层1和软骨下骨层2都为圆柱形,且软骨层1和软骨下骨层2的圆柱形底面直径一致;“莲藕状”孔3贯穿了软骨层1和软骨下骨层2的圆柱形底面;“辐射状”孔4位于软骨层1的圆柱形侧壁上,横向贯穿了软骨层1。It can be seen from Fig. 1, Fig. 2 and Fig. 3 that the osteochondral tissue repair scaffold provided by this embodiment includes an
优选的,所述软骨层1和软骨下骨层2的“莲藕状”和“辐射状”孔的孔隙直径为200μm。Preferably, the "lotus root-shaped" and "radial" pores of the
优选的,“辐射状”孔3可设有一层或一层以上,每层之间的间隔大于100μm,均匀分布于软骨层1。本实施例中,“辐射状”孔3共设有三层,由上至下均匀排列,若需要制备尺寸较大的骨软骨组织修复支架,或是软骨层1较厚时,可以设置更多层的“辐射状”孔3。Preferably, "radial" holes 3 may be provided in one or more layers, and the interval between each layer is greater than 100 μm, evenly distributed in the
优选的,每层设有2~10条横向贯穿软骨层1且经过横截面圆心的“辐射状”孔3。本实施例中每层共设有5条“辐射状”孔3。若需要制备尺寸较大的骨软骨组织修复支架,或是软骨层1横截面直径较大时时,可以在每一层设置更多条“辐射状”孔3。Preferably, each layer is provided with 2 to 10 "radial" holes 3 transversely penetrating the
优选的,在同一层的相邻两条“辐射状”孔3之间夹角都保持一致。在本实施例中,由于设置了5条“辐射状”孔3,因此每两条相邻的“辐射状”孔3之间的夹角为36度角。Preferably, the included angles between two adjacent "radial" holes 3 on the same layer are consistent. In this embodiment, since five "radial" holes 3 are provided, the angle between every two adjacent "radial" holes 3 is 36 degrees.
优选的,所述“莲藕状”孔4可设置多条,每条之间的间距大于100μm,纵向均匀分布于软骨层1和软骨下骨层2的横截面。本实施例中,共设有30条“莲藕状”孔4,均匀分布。Preferably, a plurality of "lotus root-shaped" holes 4 can be provided, and the distance between each hole is greater than 100 μm, and they are evenly distributed longitudinally in the cross-section of the
优选的,软骨层1包括GelMA、LAP和生长因子,软骨下骨层2含有GelMA和LAP,以及粒径为1纳米的磷酸钙纳米簇材料。粒径为1纳米的磷酸钙纳米簇材料的制备方法见CN201910068395.1。Preferably, the
优选的,所述软骨层1和软骨下骨层2的GelMA和LAP浓度相同,所述GelMA浓度为10~15%,所述LAP浓度为0.2%。Preferably, the GelMA and LAP concentrations of the
优选的,所述软骨层1的生长因子为KGN,所述KGN的浓度为200μM。Preferably, the growth factor of the
上层的软骨层1和下层的软骨下骨层2利用自制的光固化3D打印设备打印预先设计好模型结构的双层骨软骨组织修复支架。The upper layer of
本实施例提供的骨软骨组织修复支架的制备方法具体包括:The preparation method of the osteochondral tissue repair scaffold provided in this embodiment specifically includes:
(1)配制第一料液,第一料液包括GelMA、LAP及KGN。具体的,将GelMA、LAP及KGN在避光的条件下加入到42℃水浴的单蒸水中,搅拌均匀后,得到第一料液。其中,GelMA的浓度为15%,LAP的浓度为0.2%,KGN的浓度为200μM。(1) Prepare the first feed liquid, the first feed liquid includes GelMA, LAP and KGN. Specifically, GelMA, LAP and KGN were added into single distilled water in a water bath at 42° C. under the condition of avoiding light, and stirred evenly to obtain the first feed liquid. Among them, the concentration of GelMA is 15%, the concentration of LAP is 0.2%, and the concentration of KGN is 200 μM.
(2)配制第二料液,第二料液包括GelMA、LAP和1纳米磷酸钙纳米簇材料。具体的,将GelMA、LAP和1纳米磷酸钙纳米簇材料加入到42℃水浴的单蒸水中,搅拌均匀后,得到第二料液。其中,GelMA的浓度为15%,LAP的浓度为0.2%。(2) Prepare the second feed liquid, the second feed liquid includes GelMA, LAP and 1 nanometer calcium phosphate nanocluster material. Specifically, GelMA, LAP and 1 nanometer calcium phosphate nanocluster material were added to single distilled water in a water bath at 42° C., and stirred evenly to obtain a second feed solution. Among them, the concentration of GelMA is 15%, and the concentration of LAP is 0.2%.
(3)将6mL第一料液倒入自制的光固化3D打印设备的42℃加热的液体槽中,在打印后得到上层软骨层支架;将液体槽中剩余的第一料液转移,并用单蒸水将液体槽清洗干净后,将6mL的第二料液倒入42℃加热的液体槽中,继续进行打印,得到一体化双层骨软骨组织修复支架。(3) Pour 6mL of the first material liquid into the liquid tank heated at 42°C in the self-made light-curing 3D printing equipment, and obtain the upper cartilage layer scaffold after printing; transfer the remaining first material liquid in the liquid tank, and use a single After cleaning the liquid tank with distilled water, pour 6mL of the second material liquid into the liquid tank heated at 42°C, and continue printing to obtain an integrated double-layer osteochondral tissue repair scaffold.
(4)根据设计的CAD模型,打印完的双层骨软骨组织修复支架由两部分组成。上层软骨层,具有横向贯通的孔径为200μm的微孔,用于诱导促进软骨细胞迁移和分布;以及具有纵向贯通的孔径为200μm的微孔,用于诱导软骨细胞及骨髓间充质干细胞迁移。下层软骨下骨层,具有与上层软骨层纵向相互贯通的孔径为200μm的微孔,用于引导骨髓间充质干细胞迁移到上部空间。且双层骨软骨组织修复支架的厚度为4mm,上层软骨层的厚度为1mm,下层软骨下骨层的厚度为3mm。(4) According to the designed CAD model, the printed double-layer osteochondral tissue repair scaffold consists of two parts. The upper cartilage layer has transversely penetrating micropores with a diameter of 200 μm for inducing and promoting the migration and distribution of chondrocytes; and has longitudinally penetrating micropores with a diameter of 200 μm for inducing the migration of chondrocytes and bone marrow mesenchymal stem cells. The lower subchondral bone layer has micropores with a diameter of 200 μm longitudinally interpenetrating with the upper cartilage layer for guiding bone marrow mesenchymal stem cells to migrate to the upper space. And the thickness of the double-layer osteochondral tissue repair scaffold is 4 mm, the thickness of the upper cartilage layer is 1 mm, and the thickness of the lower subchondral bone layer is 3 mm.
图4为本发明提供的双层骨软骨组织修复支架的3D模型及制备示意图。图5为本发明提供的双层骨软骨组织修复支架的大体图。(a)支架顶视图;(b)上层支架侧视图;(c)下层支架侧视图。图6为本发明提供的双层骨软骨组织修复支架中孔隙的荧光图和电镜图。从电镜图也可以看出,凝胶本身存在多孔结构。(a)上层支架“莲藕状”和“辐射状”结构的荧光图;(b)上层支架侧面的扫描电镜图。图4-6表明本发明的双层骨软骨组织修复支架通过DLP可以打印直径为4mm,上层支架为1mm厚度,下层支架为3mm厚度,且孔径为200μm的精确双层结构。Fig. 4 is a 3D model and a schematic diagram of preparation of the double-layer osteochondral tissue repair scaffold provided by the present invention. Fig. 5 is a general view of the double-layer osteochondral tissue repair scaffold provided by the present invention. (a) Top view of the bracket; (b) Side view of the upper bracket; (c) Side view of the lower bracket. Fig. 6 is a fluorescence image and an electron microscope image of the pores in the double-layer osteochondral tissue repair scaffold provided by the present invention. It can also be seen from the electron microscope images that the gel itself has a porous structure. (a) Fluorescence image of the “lotus root-like” and “radial” structures of the upper scaffold; (b) SEM image of the side of the upper scaffold. Figures 4-6 show that the double-layer osteochondral tissue repair scaffold of the present invention can print a precise double-layer structure with a diameter of 4 mm, a thickness of the upper layer of 1 mm, a thickness of the lower layer of 3 mm, and a pore diameter of 200 μm through DLP.
实施例2不同GelMA浓度,不同孔径支架对双层骨软骨组织修复支架力学性能的影响Example 2 Effects of Different GelMA Concentrations and Different Aperture Scaffolds on the Mechanical Properties of Double-Layer Osteochondral Tissue Repair Scaffolds
本实施例为使用拉伸-压缩力学测试仪(具有1kN传感器的Instron-5543)对10%和15%两种GelMA浓度形成的不同孔径的水凝胶支架分别进行力学测试,具体实施步骤如下:In this embodiment, mechanical tests are carried out on hydrogel scaffolds with different pore sizes formed by two GelMA concentrations of 10% and 15% using a tensile-compression mechanical tester (Instron-5543 with a 1kN sensor), and the specific implementation steps are as follows:
(1)使用DLP打印机打印莲藕状的10%和15%两种浓度的下层软骨下骨层GelMA水凝胶支架,支架孔洞直径分别为0μm、100μm、200μm和400μm。(1) Use a DLP printer to print lotus root-shaped GelMA hydrogel scaffolds with two concentrations of 10% and 15% in the lower subchondral bone layer. The diameters of the scaffold holes are 0 μm, 100 μm, 200 μm and 400 μm, respectively.
(2)将打印后的GelMA水凝胶支架在1xPBS中孵育4小时;(2) Incubate the printed GelMA hydrogel scaffold in 1xPBS for 4 hours;
(3)将待测试的水凝胶支架置于力学测试仪的载物台上,设置探头按照1mm/min的速度向下压支架,直到支架高度变为初始高度的65%。电脑自动记录压缩形变和压力数据。(3) Place the hydrogel bracket to be tested on the stage of the mechanical tester, and set the probe to press down the bracket at a speed of 1 mm/min until the height of the bracket becomes 65% of the initial height. The computer automatically records compression set and pressure data.
(4)按照应变在40%-60%范围进行线性拟合计算压缩模量。(4) Calculate the compressive modulus by linear fitting according to the strain in the range of 40%-60%.
图7为本发明的上层软骨层GelMA水凝胶支架微观结构图,支架孔洞直径分别为0μm、100μm、200μm和400μm(a、b和c)。图8-10为本发明的双层骨软骨组织修复支架的最佳GelMA浓度和结构筛选。图8和图9为浓度分别为15%和10%的打印支架在支架孔洞直径分别为0μm、100μm、200μm和400μm时的载荷-压缩形变曲线和压缩模量,图10为浓度分别为15%和10%的GelMA水凝胶的扫描电镜图像。通过分别测量10%、15%两种GelMA浓度在不同孔径的力学测试的载荷和压缩形变的关系,说明不同孔径大小的支架会影响支架的力学,并且在相同情况下,孔径越大,整体力学性能相对较差。另外,15%GelMA水凝胶支架整体力学性质优于10%GelMA水凝胶力学性质。我们同样对10%GelMA和15%GelMA用扫描电镜观察水凝胶的微结构,显示水凝胶微结构均是具有多孔结构。此外计算了不同孔径的水凝胶支架的比表面积,如表1所示。Fig. 7 is a microstructure diagram of the GelMA hydrogel scaffold of the upper cartilage layer of the present invention, and the diameters of the scaffold holes are 0 μm, 100 μm, 200 μm and 400 μm (a, b and c). 8-10 are the optimal GelMA concentration and structure screening of the double-layer osteochondral tissue repair scaffold of the present invention. Figure 8 and Figure 9 are the load-compression deformation curves and compression modulus of the printed scaffolds with concentrations of 15% and 10% respectively when the diameters of the scaffold holes are 0 μm, 100 μm, 200 μm and 400 μm, and Figure 10 is the concentration of 15% respectively and SEM images of 10% GelMA hydrogels. By measuring the relationship between 10% and 15% GelMA concentrations in mechanical tests of different pore sizes, the relationship between load and compression deformation shows that scaffolds with different pore sizes will affect the mechanics of the stent, and under the same conditions, the larger the pore size, the better the overall mechanical properties. The performance is relatively poor. In addition, the overall mechanical properties of the 15% GelMA hydrogel scaffold are better than those of the 10% GelMA hydrogel. We also observed the microstructure of hydrogels with scanning electron microscope for 10% GelMA and 15% GelMA, which showed that the microstructures of hydrogels were all porous. In addition, the specific surface area of hydrogel scaffolds with different pore sizes was calculated, as shown in Table 1.
表1不同孔径的水凝胶支架的比表面积Table 1 The specific surface area of hydrogel scaffolds with different pore sizes
最终,通过材料结构的力学筛选以及支架整体表面积比较,孔径越大,软骨修复支架的比表面积越大,但孔径增大后,容易造成力学支撑性能的降低。本发明决定选择15%GelMA水凝胶的200μm孔径作为使用的支架,该水凝胶支架既具有较好的力学性质,又具有较大的支架比表面积。(*p<0.05,**p<0.01)Finally, through the mechanical screening of the material structure and the comparison of the overall surface area of the scaffold, the larger the pore size, the larger the specific surface area of the cartilage repair scaffold, but the increase in the pore size will easily lead to a decrease in the mechanical support performance. The present invention decides to select 15% GelMA hydrogel with a pore size of 200 μm as the scaffold used, and the hydrogel scaffold not only has better mechanical properties, but also has a larger specific surface area of the scaffold. (*p<0.05, **p<0.01)
实施例3上下层水凝胶支架的力学测试The mechanical test of
本实施例为使用拉伸-压缩力学测试仪(具有1kN传感器的Instron-5543)对上下层水凝胶支架分别进行力学测试,具体实施步骤如下:In this embodiment, a tensile-compression mechanical tester (Instron-5543 with a 1kN sensor) is used to perform mechanical tests on the upper and lower hydrogel supports respectively. The specific implementation steps are as follows:
(1)将打印后的上下层水凝胶支架在1xPBS中孵育4小时;(1) Incubate the printed upper and lower hydrogel scaffolds in 1xPBS for 4 hours;
(2)将待测试的水凝胶支架置于力学测试仪的载物台上,设置探头按照1mm/min的速度向下压支架,直到支架高度变为初始高度的45%。电脑自动记录压缩形变和压力数据。(2) Place the hydrogel bracket to be tested on the stage of the mechanical tester, and set the probe to press down the bracket at a speed of 1 mm/min until the height of the bracket becomes 45% of the initial height. The computer automatically records compression set and pressure data.
(3)按照应变在20%-40%范围进行线性拟合计算压缩模量。(3) Calculate the compressive modulus by linear fitting according to the strain in the range of 20%-40%.
图11为双层骨软骨组织修复支架上下层水凝胶支架的力学性质,说明下层软骨下骨层力学性能明显强于上层软骨层,符合天然骨软骨中软骨与软骨下骨之间的生物学差异,表明本发明的双层骨软骨组织修复支架具有优异的仿生力学性能。Figure 11 shows the mechanical properties of the upper and lower hydrogel scaffolds of the double-layer osteochondral tissue repair scaffold, indicating that the mechanical properties of the lower subchondral bone layer are significantly stronger than the upper cartilage layer, which is in line with the biological relationship between cartilage and subchondral bone in natural osteochondral tissue The differences indicate that the double-layer osteochondral tissue repair scaffold of the present invention has excellent bionic mechanical properties.
实施例4用CCK-8测定细胞在GelMA水凝胶的细胞活性测试
本实施例使用CCK-8测定细胞在GelMA水凝胶的细胞活性测试,所述GelMA水凝胶分为两组,第一组仅含有GelMA和LAP,第二组为空白对照,具体实施步骤如下:In this example, CCK-8 is used to measure the cell activity of cells in GelMA hydrogel. The GelMA hydrogel is divided into two groups, the first group contains only GelMA and LAP, and the second group is a blank control. The specific implementation steps are as follows :
(1)配制第二料液,第二料液中GelMA的浓度为15%、LAP的浓度为0.2%。(1) Prepare the second feed liquid, the concentration of GelMA in the second feed liquid is 15%, and the concentration of LAP is 0.2%.
(2)将配制的第二料液加入到96孔板中,其中每孔加入50μL,用紫外光进行交联后,浸泡在低糖培养基中。(2) The prepared second feed solution was added to a 96-well plate, wherein 50 μL was added to each well, cross-linked with ultraviolet light, and soaked in a low-sugar medium.
(3)在浸泡24h后,将细胞按照1000cells/孔进行接种,待24h贴壁后,弃去原培养基,加入新的培养基,每孔100μL;空白对照组加入新鲜培养基;阳性对照组只加入细胞悬液。每个实验组6个重复。(3) After soaking for 24 hours, inoculate the cells at 1000 cells/well. After 24 hours of attachment, discard the original medium and add new medium, 100 μL per well; add fresh medium to the blank control group; add fresh medium to the positive control group Add only the cell suspension. Each experimental group has 6 repetitions.
(4)检测1、3、5天的细胞增殖率。检测前,向每个孔中加入10μL CCK-8试剂,并将96孔板放置在37℃,5%CO2湿度培养箱中孵育1小时。孵育后,将每孔的培养基吸出单独放一个96孔板中,酶标仪OD值450nm处测量,进行细胞增殖数据记录和处理。(4) Detect the cell proliferation rate at 1, 3, and 5 days. Before detection, add 10 μL of CCK-8 reagent to each well, and place the 96-well plate in a 37°C, 5% CO2 humidified incubator for 1 hour. After incubation, the culture medium in each well was aspirated and put into a 96-well plate separately, and the OD value was measured at 450nm with a microplate reader, and the cell proliferation data was recorded and processed.
图12为骨软骨组织修复支架的GelMA水凝胶的生物相容性,说明细胞呈明显增殖状态,GelMA具有良好的生物相容性,有利于细胞增殖,表明本发明的骨软骨组织修复支架具有良好的生物相容性。Figure 12 is the biocompatibility of the GelMA hydrogel of the osteochondral tissue repair scaffold, indicating that the cells are in a state of obvious proliferation, and GelMA has good biocompatibility, which is conducive to cell proliferation, indicating that the osteochondral tissue repair scaffold of the present invention has Good biocompatibility.
实施例5用ALP定性和定量测定GelMA水凝胶的成骨诱导能力Example 5 Qualitative and Quantitative Determination of Osteogenic Inductive Ability of GelMA Hydrogel with ALP
本实施例使用碱性磷酸酶(ALP)定性和定量测定GelMA水凝胶的成骨诱导能力,所述GelMA水凝胶分为三组,第一组仅含有GelMA和LAP,第二组含有GelMA、LAP和粒径为1纳米的磷酸钙纳米簇材料(图中简称为CaP),第三组含有GelMA、LAP和粒径为20纳米的商业羟基磷灰石(图中简称为HANP),具体实施步骤如下:This embodiment uses alkaline phosphatase (ALP) to qualitatively and quantitatively determine the osteogenic induction ability of GelMA hydrogels. The GelMA hydrogels are divided into three groups, the first group contains only GelMA and LAP, and the second group contains GelMA , LAP and calcium phosphate nanocluster materials with a particle size of 1 nm (abbreviated as CaP in the figure), the third group contains GelMA, LAP and commercial hydroxyapatite with a particle size of 20 nm (abbreviated as HANP in the figure), specifically The implementation steps are as follows:
(1)配制第二料液,第二料液中GelMA的浓度为15%、LAP的浓度为0.2%,其中第二、三组还需添加1纳米的磷酸钙纳米簇材料或粒径为20纳米的商业羟基磷灰石。(1) prepare the second feed liquid, the concentration of GelMA in the second feed liquid is 15%, the concentration of LAP is 0.2%, wherein the second and third groups also need to add 1 nanometer calcium phosphate nano-cluster material or particle diameter is 20 Nanoscale commercial hydroxyapatite.
(2)将配制的第二料液加入到48孔板中,其中每孔加入150μL,用紫外光进行交联后,浸泡在低糖培养基中。(2) The prepared second feed solution was added to a 48-well plate, wherein 150 μL was added to each well, cross-linked with ultraviolet light, and soaked in a low-sugar medium.
(3)在浸泡24h后,将细胞按照1×105cells/孔进行接种,待细胞贴壁并长满至80%后,弃去原培养基,加入新的成骨诱导培养基,每孔250μL。每个实验组4个重复。(3) After soaking for 24 hours, inoculate the cells at 1×10 5 cells/well. After the cells adhere to the wall and grow to 80%, the original medium is discarded, and new osteogenic induction medium is added to each well. 250 μL. Each experimental group has 4 repetitions.
(4)在细胞开始成骨诱导后的第七天对其进行碱性磷酸酶显色实验和碱性磷酸酶定量实验,进行样本的碱性磷酸酶数据记录和处理。(4) The alkaline phosphatase chromogenic experiment and the alkaline phosphatase quantitative experiment were carried out on the seventh day after the cells started osteogenic induction, and the alkaline phosphatase data recording and processing of the samples were carried out.
图13-14为第7天样本的碱性磷酸酶活性定性染色和定量结果,说明GelMA与粒径为1纳米的磷酸钙纳米簇材料组合,具有比GelMA与粒径为20纳米的商业羟基磷灰石更加良好的成骨诱导性能,有利于细胞成骨分化,表明本发明的骨软骨组织修复支架具有良好的成骨诱导性。Figures 13-14 are the qualitative staining and quantitative results of the alkaline phosphatase activity of the samples on the 7th day, indicating that the combination of GelMA and calcium phosphate nanocluster materials with a particle size of 1 nm has a higher ratio than GelMA and commercial hydroxyl phosphorus with a particle size of 20 nm. The better osteogenic inductivity of the limestone is beneficial to the osteogenic differentiation of cells, indicating that the osteochondral tissue repair scaffold of the present invention has good osteogenic inductivity.
实施例6支架的微孔对体外细胞迁移实验的影响The influence of the micropore of
本实施例为水凝胶支架体外细胞迁移实验,具体实施步骤如下:This embodiment is an in vitro cell migration experiment of a hydrogel scaffold, and the specific implementation steps are as follows:
(1)将细胞进行DiI染色,即用PBS或无血清培养基稀释DiI储存液到2μM/mL工作液,用胰酶消化细胞,离心后,用工作液重悬细胞,放置到37℃,5%CO2湿度培养箱20min。结束后离心弃上清,用移液枪缓慢加入37℃预热培养基。再离心,总共洗两次。(1) Stain the cells with DiI, that is, dilute the DiI stock solution with PBS or serum-free medium to 2 μM/mL working solution, digest the cells with trypsin, centrifuge, resuspend the cells with the working solution, and place them at 37°C for 5 %CO 2 humidity incubator for 20min. After the end, the supernatant was discarded by centrifugation, and the 37°C preheated medium was slowly added with a pipette gun. Centrifuge again for a total of two washes.
(2)将DiI染好的C3H细胞按照5×105cells/mL种植在3.5cm培养皿上,贴附24h后,换液。(2) The DiI-stained C3H cells were planted on a 3.5 cm culture dish at 5×10 5 cells/mL, and the medium was changed after 24 hours of attachment.
(3)将打印好的有孔径为200μm的“莲藕状”和“辐射状”孔的下层软骨下骨层支架,和打印的无微孔(但凝胶中本身存在随机的多孔结构)的支架轻轻放置在培养皿中间,确保培养基液体浸没支架。(3) The printed lower subchondral bone scaffold with "lotus root-shaped" and "radial" pores with a pore size of 200 μm, and the printed scaffold without micropores (but there is a random porous structure in the gel itself) Gently place in the middle of the Petri dish, making sure the medium liquid submerges the holder.
(4)实验后第一天收两组的支架样品,第3、5天收有微孔的支架样品。收获的支架样品用奥林巴斯正置双光子共聚焦显微镜进行观察、拍摄,并用Imaris进行三维图像重建和数据处理。(4) The scaffold samples of the two groups were collected on the first day after the experiment, and the scaffold samples with micropores were collected on the 3rd and 5th days. The harvested scaffold samples were observed and photographed with an Olympus upright two-photon confocal microscope, and three-dimensional image reconstruction and data processing were performed with Imaris.
图15为细胞在有微孔和无微孔的支架样本上迁移后细胞数量的定量分析。表明本发明的双层骨软骨组织修复支架中的200μm孔径的“莲藕状”和“辐射状”孔结构能有效促进细胞迁移进入支架,从而在体内修复实验中达到促进缺损修复的效果,而如果未通过光固化3D打印设备打印特定的200μm孔径的“莲藕状”和“辐射状”孔结构的凝胶,虽然其本身也带有垂直孔和圆形孔,其细胞迁移效果仍然较差,难以实现足够的缺损修复效果。Figure 15 is a quantitative analysis of cell numbers after migration of cells on scaffold samples with and without micropores. It shows that the "lotus root-shaped" and "radial" pore structures with a pore size of 200 μm in the double-layer osteochondral tissue repair scaffold of the present invention can effectively promote cell migration into the scaffold, thereby achieving the effect of promoting defect repair in vivo repair experiments, and if The gel with a specific 200 μm pore size "lotus root-like" and "radiant-like" pore structure has not been printed by photocuring 3D printing equipment. Although it also has vertical and circular holes, its cell migration effect is still poor and it is difficult to Sufficient defect repair effect is achieved.
实施例7支架的微孔对体内细胞迁移实验的影响Influence of the micropores of the support in embodiment 7 on the cell migration experiment in vivo
本实施例为水凝胶支架体内细胞迁移实验,具体实施步骤如下:This embodiment is an in vivo cell migration experiment of a hydrogel scaffold, and the specific implementation steps are as follows:
(1)在无菌环境下,打印有孔径为200μm的“莲藕状”和“辐射状”孔的下层软骨下骨层支架和无微孔(但凝胶中本身存在随机的多孔结构)的支架。(1) In a sterile environment, the scaffolds of the lower subchondral bone layer with "lotus root-shaped" and "radial" pores with a pore size of 200 μm and scaffolds without micropores (but there are random porous structures in the gel itself) were printed .
(2)使用戊巴比妥对SPF级SD大鼠(250g左右,雄鼠)进行麻醉,即将戊巴比妥注射入大鼠腹腔,注射剂量为50mg/kg。(2) SPF grade SD rats (about 250 g, male) were anesthetized with pentobarbital, that is, pentobarbital was injected into the abdominal cavity of the rats, and the injection dose was 50 mg/kg.
(3)在无菌环境下,在大鼠背部内侧皮肤切开约2cm长度切口,将两种GelMA水凝胶支架分别放置到其中,然后进行缝合。(3) Under a sterile environment, an incision about 2 cm in length was made in the inner skin of the back of the rat, and the two GelMA hydrogel scaffolds were respectively placed in it, and then sutured.
(4)在术后第3、5天进行取样,4%甲醛固定24h以上。待组织固定完成后,将组织在4℃冰箱用20%、30%的蔗糖梯度脱水,待组织块沉底后取出进行冰冻切片。(4) Samples were taken on the 3rd and 5th day after operation, and fixed with 4% formaldehyde for more than 24 hours. After the tissue fixation was completed, the tissue was dehydrated in a 4°C refrigerator with a gradient of 20% and 30% sucrose, and the tissue block was taken out for frozen section after sinking to the bottom.
(5)DAPI按照1:1000比例染色切片15分钟后,PBS洗3遍;(5) DAPI stained the sections at a ratio of 1:1000 for 15 minutes, then washed 3 times with PBS;
(6)奥林巴斯正置双光子共聚焦显微镜进行观察,并用Imaris进行三维图像重建和数据处理。(6) Olympus upright two-photon confocal microscope was used for observation, and Imaris was used for three-dimensional image reconstruction and data processing.
图16为将打印和未打印的GelMA水凝胶支架皮下植入大鼠体内以评估体内细胞浸润情况,在植入第5天,打印的有200μm孔径的“莲藕状”和“辐射状”孔的下层软骨下骨层支架浸入细胞数量极显著高于无微孔的支架。表明本发明的双层骨软骨组织修复支架中的微孔结构能有效促进细胞迁移进入支架,从而在体内修复实验中达到促进缺损修复的效果。Figure 16 shows the subcutaneous implantation of printed and unprinted GelMA hydrogel scaffolds in rats to evaluate in vivo cell infiltration. On
实施例8不同的微孔分布的水凝胶支架对体内细胞迁移实验的影响Example 8 Effects of hydrogel scaffolds with different micropore distributions on in vivo cell migration experiments
本实施例为水凝胶支架体内细胞迁移实验,分别采用四种不同微孔分布的支架进行实验,其中第一种为:打印的有200μm孔径的“莲藕状”和“辐射状”孔的骨软骨组织修复支架;第二种为:打印的有200μm孔径的“莲藕状”的骨软骨组织修复支架;第三种为:打印的有200μm孔径的“辐射状”孔的骨软骨组织修复支架;第四种为:无打印微孔的骨软骨组织修复支架。This example is the in vivo cell migration experiment of the hydrogel scaffold. Four kinds of scaffolds with different micropore distribution were used for the experiment, the first one is: the printed bone with 200 μm aperture of "lotus root" and "radial" pores Cartilage tissue repair scaffold; the second type is: printed "lotus root-shaped" osteochondral tissue repair scaffold with 200μm pore size; the third type is: printed osteochondral tissue repair scaffold with 200μm "radial" holes; The fourth type is: Osteochondral tissue repair scaffold without printing micropores.
具体实施步骤如下:The specific implementation steps are as follows:
(1)在无菌环境下,打印有孔径为200μm的“莲藕状”和“辐射状”孔的水凝胶支架和无微孔(但凝胶中本身存在随机的多孔结构)的支架。(1) In a sterile environment, hydrogel scaffolds with "lotus root-shaped" and "radial" pores with a pore size of 200 μm and scaffolds without micropores (but there are random porous structures in the gel itself) were printed.
(2)使用戊巴比妥对SPF级SD大鼠(250g左右,雄鼠)进行麻醉,即将戊巴比妥注射入大鼠腹腔,注射剂量为50mg/kg。(2) SPF grade SD rats (about 250 g, male) were anesthetized with pentobarbital, that is, pentobarbital was injected into the abdominal cavity of the rats, and the injection dose was 50 mg/kg.
(3)在无菌环境下,在大鼠背部内侧皮肤切开约2cm长度切口,分别将四种GelMA水凝胶支架放置到其中,然后进行缝合。(3) Under a sterile environment, an incision about 2 cm in length was made in the inner skin of the back of the rat, and four kinds of GelMA hydrogel scaffolds were placed in it, and then sutured.
(4)在术后第5天进行取样,4%甲醛固定24h以上。待组织固定完成后,将组织在4℃冰箱用20%、30%的蔗糖梯度脱水,待组织块沉底后取出进行冰冻切片。(4) Samples were taken on the 5th day after operation and fixed with 4% formaldehyde for more than 24 hours. After the tissue fixation was completed, the tissue was dehydrated in a 4°C refrigerator with a gradient of 20% and 30% sucrose, and the tissue block was taken out for frozen section after sinking to the bottom.
(5)DAPI按照1:1000比例染色切片15分钟后,PBS洗3遍;(5) DAPI stained the sections at a ratio of 1:1000 for 15 minutes, then washed 3 times with PBS;
(6)奥林巴斯正置双光子共聚焦显微镜进行观察,并用Imaris进行三维图像重建和数据处理。结果如表2、图17、图18所示。(6) Olympus upright two-photon confocal microscope was used for observation, and Imaris was used for three-dimensional image reconstruction and data processing. The results are shown in Table 2, Figure 17, and Figure 18.
(7)将切片进行HE染色,即苏木精避光染色10分钟后,1%盐酸酒精快速分色,伊红染色20秒,然后梯度酒精脱水、二甲苯透明后,用中性树脂封片。用奥林巴斯VS200数字切片扫描仪扫描染色结果。结果如图19所示。(7) Stain the slices with HE, that is, after hematoxylin staining in the dark for 10 minutes, quickly separate the color with 1% hydrochloric acid alcohol, and stain with eosin for 20 seconds, then dehydrate with gradient alcohol, transparent with xylene, and seal the slide with neutral resin . Staining results were scanned with an Olympus VS200 digital slide scanner. The result is shown in Figure 19.
表2 5天后不同的微孔分布的水凝胶支架对体内细胞迁移实验的影响Table 2 Effects of hydrogel scaffolds with different pore distributions on in vivo cell migration experiments after 5 days
图17为植入支架后,第5天时,荧光染色灰度图;图18为荧光染色分析结果;图19为支架切片HE染色结果,其中a为“辐射状”,b为“莲藕状”孔。Figure 17 is the grayscale image of fluorescence staining on
由图19可以看出,参照示意图指示,在第5天时,没有200μm微孔的支架处,细胞只能黏附于支架表面,向支架内部迁移的能力有限。但在有打印的微孔处,细胞可以通过孔向内部迁移,无论是“莲藕状”孔还是“辐射状”孔,都对其迁移和分布起到了巨大的作用。It can be seen from Figure 19 that, referring to the schematic diagram, on
由表2和图17、18可以看出,同时含有200μm的“莲藕状”和“辐射状”孔的骨软骨组织修复支架,相比不含有微孔,或是只含有“莲藕状”或“辐射状”孔的骨软骨组织修复支架相比,其第5天时的细胞迁移数都明显提高;这是由于当骨软骨组织修复支架同时具备“莲藕状”和“辐射状”分布的孔时,非常有利于软骨细胞迁移和分布,并且还能引导骨髓间充质干细胞(BMSCs)迁移到上部空间,从而大幅提升细胞迁移数。It can be seen from Table 2 and Figures 17 and 18 that the osteochondral tissue repair scaffolds that contain both "lotus root-shaped" and "radial" holes of 200 μm, compared with those that do not contain micropores, or only contain "lotus root-shaped" or " Compared with the osteochondral tissue repair scaffold with "radial" holes, the number of cell migration on the 5th day was significantly increased; this is because when the osteochondral tissue repair scaffold has both "lotus root" and "radial" pores, It is very conducive to the migration and distribution of chondrocytes, and can also guide bone marrow mesenchymal stem cells (BMSCs) to migrate to the upper space, thereby greatly increasing the number of cell migration.
本实施例还进一步比较了“辐射状”孔位于软骨层、或是位于软骨下骨层、或是同时分布在软骨层和软骨下骨层的情况,实验证明,当“辐射状”孔仅位于软骨下骨层时,细胞迁移效果与第二种“莲藕状”的骨软骨组织修复支架类似;当“辐射状”同时分布在软骨层和软骨下骨层时,细胞迁移效果依然不佳;只有当“辐射状”孔位于软骨层,软骨下骨层不含有“辐射状”时,才能获得细胞迁移个数达到354.5±12.19个,细胞迁移深度达到279.0±56.90微米的效果。This embodiment further compares the situation that the "radial" holes are located in the cartilage layer, or in the subchondral bone layer, or are distributed in both the cartilage layer and the subchondral bone layer. The experiment proves that when the "radial" holes are only located in the In the subchondral bone layer, the cell migration effect is similar to that of the second "lotus root-shaped" osteochondral tissue repair scaffold; when the "radial shape" is distributed in both the cartilage layer and the subchondral bone layer, the cell migration effect is still poor; only When the "radial" holes are located in the cartilage layer and the subchondral bone layer does not contain "radial", the number of cell migration can reach 354.5±12.19, and the cell migration depth can reach 279.0±56.90 microns.
实施例9骨软骨支架在兔子软骨缺损部位的修复再生实验Example 9 Repair and regeneration experiment of osteochondral scaffold in rabbit cartilage defect
本实施例为水凝胶支架在兔子骨软骨缺损部位的修复再生实验,具体实施步骤如下:This embodiment is an experiment on the repair and regeneration of a hydrogel scaffold in a rabbit osteochondral defect, and the specific implementation steps are as follows:
(1)在无菌环境下,打印有200μm孔径的“莲藕状”和“辐射状”孔的双层骨软骨组织修复支架(B)、无微孔的双层骨软骨组织修复支架(NB)和上层含有生长因子KGN的有微孔的双层骨软骨GelMA水凝胶支架(B+KGN)。(1) In a sterile environment, the double-layer osteochondral tissue repair scaffold with 200 μm pore size "lotus root" and "radial" holes (B), the double-layer osteochondral tissue repair scaffold without micropores (NB) And the upper layer contains a microporous double-layer osteochondral GelMA hydrogel scaffold (B+KGN) containing growth factor KGN.
(2)使用1%戊巴比妥钠对新西兰大白兔进行耳缘静脉麻醉,注射剂量为40mg/kg。(2) New Zealand white rabbits were anesthetized with 1% sodium pentobarbital in the ear vein, and the injection dose was 40 mg/kg.
(3)在无菌环境下,用碘伏消毒皮肤,沿髌韧带内侧切开大致1cm切口,继续切开直到暴露膝关节,用有刻度的手动钻孔器在股骨滑车处取4mm直径4mm深度的孔洞,完成骨软骨软缺损造模。48只新西兰大白兔全部进行造模,造模完成后,随机分为4组:空白组,未打印组,打印双层支架组,打印上层含有生长因子KGN的双层支架组,共8周(n=4)和16周(n=8,其中4个样本用于力学测试)两个时间点。将支架按照方向放入缺损部位后,立即碘伏消毒,缝合。空白组造模后,不需要填充支架,直接消毒缝合。(3) Under a sterile environment, disinfect the skin with povidone iodine, make a roughly 1cm incision along the medial side of the patellar ligament, continue to cut until the knee joint is exposed, and take a 4mm diameter and 4mm depth at the femoral trochlea with a graduated manual drill Hole in the hole to complete the modeling of osteochondral soft defect. All 48 New Zealand white rabbits were modeled. After the modeling was completed, they were randomly divided into 4 groups: the blank group, the unprinted group, the printed double-layer scaffold group, and the printed double-layer scaffold group containing growth factor KGN on the upper layer, for a total of 8 weeks ( n=4) and 16 weeks (n=8, of which 4 samples were used for mechanical testing) two time points. After the stent was placed in the defect according to the direction, it was immediately disinfected with povidone iodine and sutured. After modeling in the blank group, there was no need to fill the stent, and they were directly sterilized and sutured.
图20为植入支架后,8、16周关节样本大体图;图21为关节样本的HE染色结果;图22为关节样本的SO染色结果;图23为16周关节样本修复后的力学测试结果。Figure 20 is the general picture of the joint samples at 8 and 16 weeks after implantation of the stent; Figure 21 is the HE staining results of the joint samples; Figure 22 is the SO staining results of the joint samples; Figure 23 is the mechanical test results of the joint samples at 16 weeks after repair .
图21-23显示,8周、16周收样评估证实,本发明的骨软骨组织修复支架不论是软骨层还是软骨下骨层,都有更好的修复效果。在SO染色中,能够观察到空白对照组的修复效果不好,有大部分骨层还未完全长成,并且有纤维组织填充物,软骨缺损部分面积减小较少。而对于含有KGN的本发明骨软骨组织修复组,修复表面光滑,基本已经完全修复,软骨层厚度正常并且软骨细胞排列整齐,与周围组织连接紧密。表明本发明的双层骨软骨组织修复支架具备可以在促进软骨下骨再生的同时促进软骨再生的能力,能有效促进骨软骨组织损伤修复。Figures 21-23 show that the evaluation of samples received at 8 weeks and 16 weeks proves that the osteochondral tissue repair scaffold of the present invention has a better repair effect whether it is the cartilage layer or the subchondral bone layer. In SO staining, it can be observed that the repair effect of the blank control group is not good, most of the bone layer has not yet fully grown, and there is fibrous tissue filling, and the area of cartilage defect is less reduced. However, for the osteochondral tissue repair group of the present invention containing KGN, the repair surface is smooth, basically completely repaired, the thickness of the cartilage layer is normal, and the chondrocytes are arranged neatly and closely connected with the surrounding tissues. It shows that the double-layer osteochondral tissue repair scaffold of the present invention has the ability to promote cartilage regeneration while promoting subchondral bone regeneration, and can effectively promote the repair of osteochondral tissue damage.
本发明未尽事宜为公知技术。Matters not covered in the present invention are known technologies.
虽然本发明披露如上,但本发明并非限定于此。任何本领域技术人员,在不脱离本发明的精神和范围内,均可作各种更动与修改,因此本发明的保护范围应当以权利要求所限定的范围为准。Although the present invention is disclosed above, the present invention is not limited thereto. Any person skilled in the art can make various changes and modifications without departing from the spirit and scope of the present invention, so the protection scope of the present invention should be based on the scope defined in the claims.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210012234.2A CN116421784A (en) | 2022-01-04 | 2022-01-04 | Osteochondral tissue repair scaffold and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210012234.2A CN116421784A (en) | 2022-01-04 | 2022-01-04 | Osteochondral tissue repair scaffold and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116421784A true CN116421784A (en) | 2023-07-14 |
Family
ID=87087777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210012234.2A Pending CN116421784A (en) | 2022-01-04 | 2022-01-04 | Osteochondral tissue repair scaffold and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116421784A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117018278A (en) * | 2023-09-04 | 2023-11-10 | 广州贝奥吉因生物科技股份有限公司 | Preparation method of 3D printing double-layer nano composite hydrogel scaffold for cartilage and bone comprehensive repair |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039420A (en) * | 2016-05-30 | 2016-10-26 | 浙江大学 | Fibrous protein material for cartilage and subchondral bone integral restoration and preparation method thereof |
| US20180021138A1 (en) * | 2016-07-22 | 2018-01-25 | Cytex Therapeutics, Inc. | Articular cartilage repair |
| KR20180112698A (en) * | 2017-03-30 | 2018-10-12 | 서울대학교산학협력단 | Bi-layered scaffold of porous ceramic and polymer with channels aligned along the one axis, preparation method thereof and using the same for osteochondral regeneration |
| CN109718249A (en) * | 2019-01-24 | 2019-05-07 | 浙江大学 | A kind of calcium phosphate nano bunch and its preparation method and application |
| CN110228193A (en) * | 2019-06-04 | 2019-09-13 | 浙江大学 | A kind of integral type colourama 3D biological printing system based on image-forming principle |
| CN112107731A (en) * | 2020-09-24 | 2020-12-22 | 武汉理工大学 | Injectable double-layer drug-loaded osteochondral repair hydrogel scaffold and preparation method thereof |
| WO2021046615A1 (en) * | 2019-09-12 | 2021-03-18 | The University Of Sydney | Compositions and method of printing ceramic materials |
| CN217697402U (en) * | 2022-01-04 | 2022-11-01 | 浙江大学 | Osteochondral tissue repair support |
-
2022
- 2022-01-04 CN CN202210012234.2A patent/CN116421784A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106039420A (en) * | 2016-05-30 | 2016-10-26 | 浙江大学 | Fibrous protein material for cartilage and subchondral bone integral restoration and preparation method thereof |
| US20180021138A1 (en) * | 2016-07-22 | 2018-01-25 | Cytex Therapeutics, Inc. | Articular cartilage repair |
| KR20180112698A (en) * | 2017-03-30 | 2018-10-12 | 서울대학교산학협력단 | Bi-layered scaffold of porous ceramic and polymer with channels aligned along the one axis, preparation method thereof and using the same for osteochondral regeneration |
| CN109718249A (en) * | 2019-01-24 | 2019-05-07 | 浙江大学 | A kind of calcium phosphate nano bunch and its preparation method and application |
| CN110228193A (en) * | 2019-06-04 | 2019-09-13 | 浙江大学 | A kind of integral type colourama 3D biological printing system based on image-forming principle |
| WO2021046615A1 (en) * | 2019-09-12 | 2021-03-18 | The University Of Sydney | Compositions and method of printing ceramic materials |
| CN112107731A (en) * | 2020-09-24 | 2020-12-22 | 武汉理工大学 | Injectable double-layer drug-loaded osteochondral repair hydrogel scaffold and preparation method thereof |
| CN217697402U (en) * | 2022-01-04 | 2022-11-01 | 浙江大学 | Osteochondral tissue repair support |
Non-Patent Citations (1)
| Title |
|---|
| YUQING GU ET AL: "3d printed biomimetic scaffolds with precisely controlled and tunable structures guide cell migration and promote regeneration of osteochondral defect", 《BIOFABRICATION》, 18 October 2023 (2023-10-18), pages 1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117018278A (en) * | 2023-09-04 | 2023-11-10 | 广州贝奥吉因生物科技股份有限公司 | Preparation method of 3D printing double-layer nano composite hydrogel scaffold for cartilage and bone comprehensive repair |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Marginal sealing around integral bilayer scaffolds for repairing osteochondral defects based on photocurable silk hydrogels | |
| Li et al. | Robotic in situ 3D bio-printing technology for repairing large segmental bone defects | |
| Wang et al. | Extracellular matrix derived from allogenic decellularized bone marrow mesenchymal stem cell sheets for the reconstruction of osteochondral defects in rabbits | |
| Xu et al. | Development of biodegradable bioactive glass ceramics by DLP printed containing EPCs/BMSCs for bone tissue engineering of rabbit mandible defects | |
| Chen et al. | PAM/GO/gel/SA composite hydrogel conduit with bioactivity for repairing peripheral nerve injury | |
| Cao et al. | Biomimetic injectable and bilayered hydrogel scaffold based on collagen and chondroitin sulfate for the repair of osteochondral defects | |
| CN101979105A (en) | Tissue engineering scaffold material for repairing cartilage defects and preparation method thereof | |
| Wang et al. | 3D bioprinting of DPSCs with GelMA hydrogel of various concentrations for bone regeneration | |
| Han et al. | Study on bioactive PEGDA/ECM hybrid bi-layered hydrogel scaffolds fabricated by electro-writing for cartilage regeneration | |
| CN110408058A (en) | A kind of galapectite composite hydrogel and its preparation method and application promoting bone defect healing | |
| Meng et al. | Decellularized laser micro-patterned osteochondral implants exhibit zonal recellularization and self-fixing for osteochondral regeneration in a goat model | |
| CN107789668A (en) | Bionical collagen bone renovating material with sandwich construction and preparation method thereof | |
| Wang et al. | 3D printed cell-free bilayer porous scaffold based on alginate with biomimetic microenvironment for osteochondral defect repair | |
| CN116421784A (en) | Osteochondral tissue repair scaffold and preparation method thereof | |
| EP3025735B1 (en) | Methods for complex tissue engineering | |
| CN217697402U (en) | Osteochondral tissue repair support | |
| CN115970054A (en) | 3D printed porous bone scaffold loaded with silicon nitride and its preparation method and application | |
| Lin et al. | Tissue-engineered cartilage constructed by a biotin-conjugated anti-CD44 avidin binding technique for the repairing of cartilage defects in the weight-bearing area of knee joints in pigs | |
| US20250135071A1 (en) | Use of polypeptide in promotion of cartilage regeneration or repair | |
| US11701232B2 (en) | Acellular bioactive scaffold device and methods of fabrication and treatment relating thereto | |
| Feng et al. | A light-cured injectable composite hydrogel based on chitosan and decellularized matrix modulates stem cell aggregation behavior for accelerating cartilage defect repair | |
| CN116271222B (en) | A bone tissue engineering scaffold and its preparation method and application | |
| CN114931670B (en) | Application of active substance and self-healing hydrogel thereof in cartilage repair | |
| CN115887775A (en) | Gradient 3D printing polycaprolactone modified scaffold for growth plate repair and its preparation method and application | |
| Yang et al. | Porcine fibrin sealant combined with autologous chondrocytes successfully promotes full‐thickness cartilage regeneration in a rabbit model |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |